Effects of oral progestogens on estrogen-induced changes in plasma proteins
Briggs, M.H.
Journal of Reproductive Medicine 15(3): 100-102
1975
ISSN/ISBN: 0024-7758 PMID: 1214250 Document Number: 91335
Document emailed within 1 workday
Related Documents
Mills, J.L.; Jefferys, J.L.; Stolley, P.D. 1984: Effects of occupational exposure to estrogen and progestogens and how to detect them Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 26(4): 269-272Sabra, A.; Bonnar, J. 1983: Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel Journal of Reproductive Medicine 28(1 Suppl): 85-91
Wiedemann, C.; Nägele, U.; Schramm, G.; Berking, C. 2009: Inhibitory effects of progestogens on the estrogen stimulation of melanocytes in vitro Contraception 80(3): 292-298
Iacobelli, S.; Natoli, V.; Scambia, G. 1984: Estrogen-induced proteins in estrogen-sensitive cells Progress in Clinical and Biological Research 142: 53-62
Knopp, R.H.; Walden, C.E.; Wahl, P.W.; Hoover, J.J.; Warnick, G.R.; Albers, J.J.; Ogilvie, J.T.; Hazzard, W.R. 1981: Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency Journal of Clinical Endocrinology and Metabolism 53(6): 1123-1132
Gambini, G.; Farina, G.; Arbosti, G. 1976: Syndrome due to estrogen-progestogens in a worker engaged in the production of contraceptive agents La Medicina del Lavoro 67(2): 152-157
van Lunsen, H.W. 1996: Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 1(1): 39-45
van Lunsen, H.W. 1996: Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 1(1): 39-45
Hayase, T.; Yamamoto, Y.; Yamamoto, K. 2002: Increased immunoreactivity of POMC-derived neuropeptides and immediate-early gene-derived proteins (c-Fos and Egr-1 proteins) as an early step of acute cocaine-induced stressor effects: comparison with the effects of immobilization stress Nihon Arukoru Yakubutsu Igakkai Zasshi 37(6): 586-596
Blankenstein, M.A.; Mulder, E.; Broerse, J.J.; Van Der Molen, H.J. 1980: Mammary gland estrogen receptors and plasma prolactin during estrogen enhanced rat mammary tumor development strain difference in the response to estrogen Radiation and Environmental Biophysics 17(4): 359
Melner, M.H.; Voigt, W.; Puett, D. 1986: Cross-reactivity of a monoclonal antibody directed against an estrogen-induced protein in MCF-7 human breast cancer cells with murine Leydig cell tumor proteins Cancer Research 46(1): 328-331
Briggs, M.H. 1983: A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives Journal of Reproductive Medicine 28(1 Suppl): 92-99
Larsson-Cohn, U.; Fåhraeus, L.; von Schenck, H.; Wallentin, L. 1986: Effects on the lipoprotein metabolism of an antiandrogen-estrogen oral contraceptive drug Acta Obstetricia et Gynecologica Scandinavica 65(2): 125-128
Jirapinyo, M.; Theppisai, U.; Manonai, J.; Suchartwatnachai, C.; Jorgensen, L.N. 2003: Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women Acta Obstetricia et Gynecologica Scandinavica 82(9): 857-866
Sitruk-Ware, R.; Nath, A. 2013: Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills Best Practice and Research. Clinical Endocrinology and Metabolism 27(1): 13-24
Newton, J.R. 1995: Classification and comparison of oral contraceptives containing new generation progestogens Human Reproduction Update 1(3): 231-263
Newton, J.R. 1995: Classification and comparison of oral contraceptives containing new generation progestogens Human Reproduction Update 1(3): 231-263
1989: The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: 2. Lack of effect of estrogen. Task Force on Oral Contraceptives. WHO Special Programme of Research, Development and Research Training in Human Reproduction Contraception 40(2): 147-156
Fex, G.; Adielsson, G.; Mattson, W. 1981: Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma Acta Endocrinologica 97(1): 109-113
Slater, C.C.; Zhang, C.; Hodis, H.N.; Mack, W.J.; Boostanfar, R.; Shoupe, D.; Paulson, R.J.; Stanczyk, F.Z. 2001: Comparison of estrogen and androgen levels after oral estrogen replacement therapy Journal of Reproductive Medicine 46(12): 1052-1056